FDA Issues Warnings on Nicotine-Containing Tobacco Products

Sep.09.2022
FDA Issues Warnings on Nicotine-Containing Tobacco Products
The FDA has sent warning letters to manufacturers and retailers about non-tobacco nicotine products, and has made progress in reviewing applications.

Since President Joe Biden signed legislation authorizing the agency to regulate tobacco products containing nicotine, the U.S. Food and Drug Administration (FDA) has sent more than 44 warning letters to manufacturers and over 300 to retailers, detailing violations related to non-tobacco nicotine (NTN) products from any source. In addition, the FDA has issued new warning letters to 102 retailers for illegally selling NTN products to minors.


In an update, the organization detailed "significant progress" in processing and reviewing applications for synthetic nicotine products for tobacco products prior to their release on the market.


On March 15, 2022, a new federal law granted the FDA the authority to regulate any tobacco products containing nicotine from any source. The law went into effect on April 14, 2022, and after July 13, 2022, any new Non-Traditional Tobacco (NTN) products that have not received prior authorization from the FDA cannot legally be sold.


The FDA has announced that it has received nearly one million new tobacco product applications from over 200 companies. According to the agency, all applications submitted before May 14th have been processed, and over 85% of them have been reviewed to determine if they meet the minimum requirements for further examination. The FDA has issued over 800,000 Refuse-to-Accept (RTA) letters for products that do not meet their standards.


The FDA has received more than 350 new tobacco product applications, the majority of which are for e-cigarettes or e-liquids. The agency emphasizes that acceptance does not determine the authorization status of the products. "Accepted applications will undergo further review to ensure they meet certain standards," the FDA wrote in its update.


For more information regarding the FDA's pre-market review progress, as well as compliance and enforcement actions, please visit the agency's NTN product webpage.


Statement


This article compiles information from third-party sources and is intended for industry professionals for educational purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the article's content. The translation of this article is only intended for internal industry research and communication.


Due to limitations in translation abilities, the translated article may not fully reflect the original text. Please refer to the original version for accuracy.


2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


The ownership of compiled information belongs to the original media and authors. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Iowa's PMTA Registration Bill Suspended: Judge Rules It Violates Federal Preemption
Iowa's PMTA Registration Bill Suspended: Judge Rules It Violates Federal Preemption
A judge in Iowa has ruled to suspend the state's PMTA registration bill (HF 2677) targeting e-cigarette products. The court found that the bill violates the federal preemption clause in the U.S. Constitution, interfering with the exclusive regulatory authority of the FDA. The bill has been put on hold pending further judicial review.
May.06 by 2FIRSTS.ai
ZYN Refreshes Packaging and Expands Line-Up in UK with Two New Flavours and Lower-Strength Options
ZYN Refreshes Packaging and Expands Line-Up in UK with Two New Flavours and Lower-Strength Options
Philip Morris International (PMI) has refreshed its ZYN nicotine pouch brand in the UK with a new packaging design and a range of flavour upgrades. The revamp includes the launch of an ultra-low strength 1.5mg option, as well as two new flavours: Spearmint and Apple Mint.
Jun.09 by 2FIRSTS.ai
India’s Vape Ban: A Case Study in Unintended Consequences | By Association of Vapers India Director for 2Firsts
India’s Vape Ban: A Case Study in Unintended Consequences | By Association of Vapers India Director for 2Firsts
Five years after India’s vape ban, illicit sales are booming and smokers are denied safer alternatives. In this exclusive piece for 2Firsts, AVI Director Samrat Chowdhery explores the policy’s unintended consequences and calls for regulatory reform.
Jun.04
Celebrating a Decade: Vapouround Global Awards Held in Dubai, 2Firsts Invited for On-Site Coverage
Celebrating a Decade: Vapouround Global Awards Held in Dubai, 2Firsts Invited for On-Site Coverage
The Vapouround 10th Anniversary Global Awards Ceremony was grandly held in Dubai, bringing together brand representatives, industry experts, and opinion leaders from around the world. Multiple major awards were announced on-site to celebrate a decade of industry achievements. 2Firsts was invited to attend and provide on-site coverage.
Jun.19 by 2FIRSTS.ai
Youth Vaping Rates Plummet: Canadian Vaping Association Urges Shift to Adult Harm Reduction Strategies
Youth Vaping Rates Plummet: Canadian Vaping Association Urges Shift to Adult Harm Reduction Strategies
Youth vaping in Canada has dropped to 7.2%, down nearly 50% from 2019, the Canadian Vaping Association says. It calls for a policy shift to support adult smokers in switching to safer alternatives.
May.22
Itsuwa Posts 194% Drop in 2024 Net Profit with $2.7M Loss, to Focus on Modular and Eco-Friendly E-Cigarettes
Itsuwa Posts 194% Drop in 2024 Net Profit with $2.7M Loss, to Focus on Modular and Eco-Friendly E-Cigarettes
Itsuwa Technology (NEEQ: 833767) released its 2024 annual report, reporting revenue of 283 million yuan, down 12.59% year-on-year, and a net loss of 19.66 million yuan, a 194.47% decline from the previous year. The company attributed the loss to intense competition and product homogeneity in overseas markets, as well as rising labor costs. Its gross profit margin dropped to 30%, while R&D spending accounted for 9.12% of revenue. Going forward, the company plans to focus on developing eco-friendl
May.13 by 2FIRSTS.ai